Provided by Tiger Trade Technology Pte. Ltd.

Amylyx Pharmaceuticals

34.74
-2.4400-6.56%
Pre-market: 34.69-0.0500-0.14%08:42 EDT
Volume:1.36M
Turnover:48.13M
Market Cap:3.86B
PE:-24.28
High:37.68
Open:36.78
Low:34.48
Close:37.18
52wk High:41.14
52wk Low:9.15
Shares:111.19M
Float Shares:109.51M
Volume Ratio:0.44
T/O Rate:1.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4309
EPS(LYR):-1.5305
ROE:-74.73%
ROA:-44.13%
PB:16.15
PE(LYR):-22.70

Loading ...

Amylyx Says FDA Grants Avexitide Breakthrough Therapy, Orphan Drug Status for Post-Bariatric Hypoglycemia

Reuters
·
Aug 18

Amylyx announces Lucidity Phase 3 trial met primary endpoint

TIPRANKS
·
Aug 18

Amylyx Pharmaceuticals: Lucidity Met FDA-Agreed-upon Primary Endpoint and All Secondary Endpoints

THOMSON REUTERS
·
Aug 18

Amylyx: Plans to Submit Nda for Avexitide with FDA by Year-End & Plans for Potential Launch in 2027, if Approved

THOMSON REUTERS
·
Aug 18

Amylyx Pharmaceuticals, - Lucidity Meets All Secondary Endpoints with Significant Reductions in Hypoglycemic Events

THOMSON REUTERS
·
Aug 18

Amylyx Pharmaceuticals, - Avexitide Generally Well-Tolerated with Favorable Safety Profile

THOMSON REUTERS
·
Aug 18

NASDAQ Trade Halt Halt News Pending at 06:55 Am

Reuters
·
Aug 18

Amylyx Shares Gains Ahead of Drug Data Readout

Dow Jones
·
Aug 18

Amylyx up 17% after announcing expected results for Avexitide tomorrow

TIPRANKS
·
Aug 18

Amylyx to Release Phase 3 Lucidity Trial Topline Results for Avexitide in Post-Bariatric Hypoglycemia Aug. 18, 2026

Reuters
·
Aug 18

U.S. Research Roundup- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies

Reuters
·
Aug 17

Toronto Stock Exchange Hits Record High as Oil Prices Rise

TIPRANKS
·
Aug 13

Is Amylyx (AMLX) Quietly Rewriting Its R&D Risk‑Reward Profile As Losses Deepen Without Revenue?

Simply Wall St.
·
Aug 10

Amylyx Pharmaceuticals (AMLX) Could Be 5% Undervalued After Second Quarter Earnings

Simply Wall St.
·
Aug 08

Emera Inc. CEO on board with plans to boost energy infrastructure in Maritimes

Bloomberg
·
Aug 07

Amylyx Pharmaceuticals Readies for Pivotal LUCIDITY Data

TIPRANKS
·
Aug 07

Amylyx Pharmaceuticals, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Earnings Flash (AMLX) Amylyx Pharmaceuticals Posts Q2 Loss $0.39 a Share, vs. FactSet Est of $0.35 Loss

MT Newswires Live
·
Aug 06

Amylyx Pharmaceuticals Q2 Posts Higher than Expected Loss

Reuters
·
Aug 06

Amylyx Q2 FY26 Net Loss Widens to $43.4 Million; SG&A Expenses Climb to $21.9 Million

Reuters
·
Aug 06